Trade Summary

3 days ago, Jacobs Bruce N., serving as CFO at Kymera Therapeutics, Inc. (KYMR), sold 12,471 shares at $87.50 per share, for a total transaction value of $1,091,231.00. Following this transaction, Jacobs Bruce N. now holds 232,588 shares of KYMR.

This sale represents a 5.00% decrease in Jacobs Bruce N.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Kymera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.